{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:31:11Z","timestamp":1791916271709,"version":"4.3.4"},"reference-count":128,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009432","name":"Government Council on Grants, Russian Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.autrev.2021.102792","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T10:15:02Z","timestamp":1613902502000},"page":"102792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":460,"title":["The SARS-CoV-2 as an instrumental trigger of autoimmunity"],"prefix":"10.1016","volume":"20","author":[{"given":"Arad","family":"Dotan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylviane","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darja","family":"Kanduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilad","family":"Halpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0005","first-page":"3","article-title":"The mosaic of autoimmunity: genetic factors involved in autoimmune diseases","volume":"10","author":"Shoenfeld","year":"2008","journal-title":"Isr. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0010","first-page":"8","article-title":"The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases","volume":"10","author":"Shoenfeld","year":"2008","journal-title":"Isr. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0015","first-page":"13","article-title":"The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases","volume":"10","author":"Shoenfeld","year":"2008","journal-title":"Isr. Med. Assoc. J."},{"issue":"8","key":"10.1016\/j.autrev.2021.102792_bb0020","first-page":"517","article-title":"Hyperstimulation of adaptive immunity as the common pathway for silicone breast implants, autoimmunity, and lymphoma of the breast","volume":"21","author":"Watad","year":"2019","journal-title":"Isr. Med. Assoc. J."},{"issue":"6","key":"10.1016\/j.autrev.2021.102792_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00296-002-0229-4","article-title":"Malignant lymphoma-associated autoimmune diseases\u2013a descriptive epidemiological study","volume":"22","author":"V\u00e1r\u00f3czy","year":"2002","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein\u2013Barr virus in autoimmune diseases","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.autrev.2021.102792_bb0035","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00002030-199209000-00004","article-title":"Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients","volume":"6","author":"Muller","year":"1992","journal-title":"Aids."},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0040","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/clin.1995.1154","article-title":"IgG autoantibody response in HTLV-I-infected patients","volume":"77","author":"Muller","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"2","key":"10.1016\/j.autrev.2021.102792_bb0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/viru.19697","article-title":"Blood-brain barrier and retroviral infections","volume":"3","author":"Miller","year":"2012","journal-title":"Virulence."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1196\/annals.1422.059","article-title":"Epstein\u2013Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report","volume":"1108","author":"Barzilai","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.autrev.2021.102792_bb0055","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/v11080762","article-title":"Autoimmunity: a review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.autrev.2021.102792_bb0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57278","article-title":"Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients","volume":"9","author":"Rossi","year":"2020","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.autrev.2021.102792_bb0065","doi-asserted-by":"crossref","first-page":"H1377","DOI":"10.1152\/ajpheart.00331.2008","article-title":"Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis","volume":"295","author":"Lovren","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"12","key":"10.1016\/j.autrev.2021.102792_bb0070","first-page":"102695","article-title":"Covid-19 and autoimmunity","volume":"19","author":"Ehrenfeld","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0075","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"Wang","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.autrev.2021.102792_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and autoimmune conditions at the crossroad of COVID-19","volume":"114","author":"Rodr\u00edguez","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.autrev.2021.102792_bb0090","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The covid-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"issue":"10229","key":"10.1016\/j.autrev.2021.102792_bb0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102792_bb0100","first-page":"1","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.autrev.2021.102792_bb0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/17476348.2020.1804365","article-title":"Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis","volume":"14","author":"Hasan","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12026-020-09152-6","article-title":"Molecular mimicry between sars-cov-2 spike glycoprotein and mammalian proteomes: implications for the vaccine","volume":"68","author":"Kanduc","year":"2020","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.autrev.2021.102792_bb0115","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/hmg\/ddn388","article-title":"Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis","volume":"18","author":"Baranzini","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0120","first-page":"1","article-title":"Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0125","first-page":"283","article-title":"A new patient with Andermann syndrome: an underdiagnosed clinical genetics entity?","volume":"24","author":"Degerliyurt","year":"2013","journal-title":"Genet. Couns."},{"issue":"7161","key":"10.1016\/j.autrev.2021.102792_bb0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature06162","article-title":"Genetic variation in a human odorant receptor alters odour perception","volume":"449","author":"Keller","year":"2007","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.autrev.2021.102792_bb0135","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","article-title":"Molecular mimicry and immune-mediated diseases","volume":"12","author":"Oldstone","year":"1998","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.autrev.2021.102792_bb0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nm.4044","article-title":"Oxidation and mitochondrial origin of NET DNA in the pathogenesis of lupus","volume":"22","author":"Muller","year":"2016","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.autrev.2021.102792_bb0145","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41584-018-0039-z","article-title":"The role of neutrophil extracellular traps in rheumatic diseases","volume":"14","author":"Apel","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.autrev.2021.102792_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41584-019-0352-1","article-title":"NETs spread ever wider in rheumatic diseases","volume":"16","author":"Wigerblad","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.autrev.2021.102792_bb0160","article-title":"Autoantibodies to neutrophil extracellular traps represent a potential serological biomarker in rheumatoid arthritis","volume":"113","author":"Bont","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.autrev.2021.102792_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00870","article-title":"Neutrophilia and NETopathy as key pathologic drivers of progressive lung impairment in patients with COVID-19","volume":"11","author":"Narasaraju","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.autrev.2021.102792_bb0170","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3390\/cells9061383","article-title":"Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19","volume":"9","author":"Tomar","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.autrev.2021.102792_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0180","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1358863X20932640","article-title":"COVID\u201319-associated coagulopathy: an exploration of mechanisms","volume":"25","author":"Colling","year":"2020","journal-title":"Vasc. Med."},{"key":"10.1016\/j.autrev.2021.102792_bb0185","first-page":"1","article-title":"Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications","author":"Merrill","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.autrev.2021.102792_bb0190","first-page":"1","article-title":"Another step forward in blood-based diagnostics for Alzheimer\u2019s disease","author":"Bateman","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.autrev.2021.102792_bb0195","series-title":"medRxiv","article-title":"Prothrombotic antiphospholipid antibodies in COVID-19","author":"Zuo","year":"2020"},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJMc2013656","article-title":"Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19","volume":"383","author":"Bowles","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autrev.2021.102792_bb0205","first-page":"1","article-title":"Blood clots and TAM receptor signalling in COVID-19 pathogenesis","author":"Lemke","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.autrev.2021.102792_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02158","article-title":"The mitochondrion-lysosome axis in adaptive and innate immunity: effect of lupus regulator peptide P140 on mitochondria autophagy and NETosis","volume":"9","author":"Bendorius","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.autrev.2021.102792_bb0215","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1136\/annrheumdis-2012-202460","article-title":"Lupuzor\/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial","volume":"72","author":"Zimmer","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.autrev.2021.102792_bb0220","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.autrev.2021.102792_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25822","article-title":"Critically-ill covid-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability","author":"Tan","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"12","key":"10.1016\/j.autrev.2021.102792_bb0230","first-page":"1998","article-title":"Brief report: anti-phospholipid antibodies in critically-ill patients with coronavirus disease 2019 COVID-19","volume":"72","author":"XiaoM","year":"2020","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.autrev.2021.102792_bb0235","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.41409","article-title":"Anti-cardiolipin IgG autoantibodies are an independent risk factor of COVID-19 severity","volume":"72","author":"Bertin","year":"2020","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0240","first-page":"462","article-title":"Inflammation in patients with lupus anticoagulant and implications for thrombosis","volume":"32","author":"Sailer","year":"2005","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0245","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/00365510601038992","article-title":"Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein","volume":"67","author":"Sidelmann","year":"2007","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.autrev.2021.102792_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.thromres.2019.03.006","article-title":"IgG phosphatidylserine\/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers","volume":"177","author":"Tonello","year":"2019","journal-title":"Thromb. Res."},{"key":"10.1016\/j.autrev.2021.102792_bb0260","series-title":"medRxiv","article-title":"Prothrombotic antiphospholipid antibodies in COVID-19","author":"Zuo","year":"2020"},{"key":"10.1016\/j.autrev.2021.102792_bb0265","series-title":"MedRxiv","article-title":"Heparin-induced thrombocytopenia is associated with a high risk of mortality in critical COVID-19 patients receiving heparin-involved treatment","author":"Liu","year":"2020"},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0270","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/rth2.12390","article-title":"Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome","volume":"4","author":"Riker","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6515","key":"10.1016\/j.autrev.2021.102792_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science."},{"issue":"12","key":"10.1016\/j.autrev.2021.102792_bb0280","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/annrheumdis-2020-218009","article-title":"Autoantibodies related to systemic autoimmune rheumatic diseases in severely-ill patients with COVID-19","volume":"79","author":"Vlachoyiannopoulos","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.autrev.2021.102792_bb0285","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/cts.12805","article-title":"Clinical and autoimmune characteristics of severe and critical cases of COVID-19","volume":"13","author":"Zhou","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0290","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08916930400022954","article-title":"Anti-Ro\/SSA and La\/SSB antibodies","volume":"38","author":"Franceschini","year":"2005","journal-title":"Autoimmunity"},{"issue":"11","key":"10.1016\/j.autrev.2021.102792_bb0295","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.41409","article-title":"Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity","volume":"72","author":"Bertin","year":"2020","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2021.102792_bb0300","first-page":"1","article-title":"Immune-mediated neurological syndromes in SARS-CoV-2-infected patients","volume":"30","author":"Guilmot","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.autrev.2021.102792_bb0305","first-page":"1","article-title":"Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies","author":"Cristiano","year":"2021","journal-title":"Res. Square"},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0310","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.autrev.2021.102792_bb0315","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI114831","article-title":"Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease","volume":"86","author":"Klinman","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"26","key":"10.1016\/j.autrev.2021.102792_bb0320","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.autrev.2021.102792_bb0325","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.clinph.2020.05.003","article-title":"Post SARS-CoV-2 Guillain-Barr\u00e9 syndrome","volume":"131","author":"Arnaud","year":"2020","journal-title":"Clin. Neurophysiol."},{"issue":"11","key":"10.1016\/j.autrev.2021.102792_bb0330","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s10072-020-04693-y","article-title":"Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports","volume":"41","author":"Rahimi","year":"2020","journal-title":"Ital. J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0335","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin. Proc."},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0340","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/WNL.0000000000009619","article-title":"Miller fisher syndrome and polyneuritis cranialis in COVID-19","volume":"95","author":"Guti\u00e9rrez-Ortiz","year":"2020","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.autrev.2021.102792_bb0345","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3174\/ajnr.A6609","article-title":"COVID-19-associated Miller Fisher syndrome: MRI findings","volume":"41","author":"Lantos","year":"2020","journal-title":"Am. J. Neuroradiol."},{"issue":"2","key":"10.1016\/j.autrev.2021.102792_bb0350","doi-asserted-by":"crossref","first-page":"e926","DOI":"10.1210\/clinem\/dgaa813","article-title":"Thyroid dysfunction in relation to immune profile, disease status and outcome in 191 patients with COVID-19","volume":"106","author":"Lui","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.autrev.2021.102792_bb0355","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s40618-020-01366-7","article-title":"SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves\u2019 disease after COVID-19","volume":"43","author":"Mateu-Salat","year":"2020","journal-title":"J. Endocrinol. Investig."},{"issue":"9","key":"10.1016\/j.autrev.2021.102792_bb0360","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(20)30266-7","article-title":"SARS-CoV-2-related atypical thyroiditis","volume":"8","author":"Muller","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"10.1016\/j.autrev.2021.102792_bb0365","doi-asserted-by":"crossref","first-page":"H1377","DOI":"10.1152\/ajpheart.00331.2008","article-title":"Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis","volume":"295","author":"Lovren","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0370","first-page":"1","article-title":"Vasculitis in COVID-19: a literature review","volume":"6","author":"Almashat","year":"2020","journal-title":"J Vasc"},{"key":"10.1016\/j.autrev.2021.102792_bb0375","series-title":"medRxiv","article-title":"IgM autoantibodies recognizing ACE2 are associated with severe COVID-19","author":"Rosen","year":"2020"},{"issue":"14","key":"10.1016\/j.autrev.2021.102792_bb0380","doi-asserted-by":"crossref","first-page":"422","DOI":"10.15585\/mmwr.mm6914e4","article-title":"Coronavirus Disease 2019 in Children\u2014United States, February 12\u2013April 2, 2020","volume":"69","author":"Bialek","year":"2020","journal-title":"Morb. Mortal. Wkly Rep."},{"issue":"14","key":"10.1016\/j.autrev.2021.102792_bb0385","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","article-title":"Kawasaki disease","volume":"67","author":"Newburger","year":"2016","journal-title":"J. Am Coll."},{"issue":"12","key":"10.1016\/j.autrev.2021.102792_bb0390","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00296-020-04701-6","article-title":"Kawasaki-like disease in children with COVID-19","volume":"40","author":"Akca","year":"2020","journal-title":"Rheumatol. Int."},{"issue":"8","key":"10.1016\/j.autrev.2021.102792_bb0395","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in Covid-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.autrev.2021.102792_bb0400","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.2337\/dc20-1551","article-title":"New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the UK","volume":"43","author":"Unsworth","year":"2020","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.autrev.2021.102792_bb0405","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00592-020-01570-0","article-title":"Type 1 diabetes onset triggered by COVID-19","volume":"57","author":"Marchand","year":"2020","journal-title":"Acta Diabetol."},{"issue":"4","key":"10.1016\/j.autrev.2021.102792_bb0410","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ajh.10062","article-title":"Autoimmune hemolytic anemia","volume":"69","author":"Gehrs","year":"2002","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0415","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bjh.16794","article-title":"Autoimmune hemolytic anemia associated with Covid-19 infection","volume":"190","author":"Lazarian","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0420","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.16786","article-title":"Simultaneous onset of COVID-19 and autoimmune Hemolytic Anemia","volume":"190","author":"Lopez","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.autrev.2021.102792_bb0425","first-page":"1679","article-title":"COVID-19 infection associated with auto-immune Hemolytic Anemia","volume":"99","author":"Capes","year":"2020","journal-title":"Res. Square"},{"key":"10.1016\/j.autrev.2021.102792_bb0430","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/psc.2419","article-title":"Homology, similarity, and identity in peptide epitope immunodefinition","volume":"8","author":"Kanduc","year":"2012","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.autrev.2021.102792_bb0435","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.16883","article-title":"Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?","author":"Angileri","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"18","key":"10.1016\/j.autrev.2021.102792_bb0440","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1056\/NEJMc2010472","article-title":"Immune thrombocytopenic purpura in a patient with Covid-19","volume":"382","author":"Zulfiqar","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.autrev.2021.102792_bb0445","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/bjh.16850","article-title":"COVID-19-associated immune thrombocytopenia","volume":"190","author":"Bomhof","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.autrev.2021.102792_bb0450","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s10067-020-05310-1","article-title":"Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology","volume":"39","author":"Mantovani","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"18","key":"10.1016\/j.autrev.2021.102792_bb0455","first-page":"9695","article-title":"The first case of systemic lupus erythematosus (sle) triggered by covid-19 infection","volume":"24","author":"Bonometti","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0460","doi-asserted-by":"crossref","DOI":"10.1007\/s10286-020-00727-9","article-title":"A case report of postural tachycardia syndrome after COVID-19","volume":"30","author":"Miglis","year":"2020","journal-title":"Clin. Auton. Res."},{"issue":"9","key":"10.1016\/j.autrev.2021.102792_bb0465","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1016\/S2665-9913(20)30216-2","article-title":"Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection","volume":"2","author":"Talarico","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"11","key":"10.1016\/j.autrev.2021.102792_bb0470","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/S2665-9913(20)30348-9","article-title":"Viral arthritis and COVID-19","volume":"2","author":"Parisi","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.autrev.2021.102792_bb0475","article-title":"MuSK antibody\u2013associated myasthenia gravis with SARS-CoV-2 infection: a case report","author":"Muhammed","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.autrev.2021.102792_bb0480","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.autrev.2021.102792_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/lary.28692","article-title":"Ageusia: common findings in COVID-19 patients","volume":"130","author":"Vaira","year":"2020","journal-title":"Laryngoscope."},{"issue":"8","key":"10.1016\/j.autrev.2021.102792_bb0490","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","volume":"277","author":"Lechien","year":"2020","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0495","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/0194599820922992","article-title":"COVID-19 Anosmia reporting tool: initial findings","volume":"163","author":"Kaye","year":"2020","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.autrev.2021.102792_bb0500","article-title":"COVID-19 and anosmia in Tehran","volume":"141","author":"Gilani","year":"2020","journal-title":"Iran Med Hypotheses"},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0505","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4193\/Rhin20.114","article-title":"Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome?","volume":"58","author":"Gane","year":"2020","journal-title":"Rhinology"},{"issue":"4","key":"10.1016\/j.autrev.2021.102792_bb0510","first-page":"1641","article-title":"Anosmia and Dysgeusia in the absence of other respiratory diseases: should COVID-19 infection be considered?","volume":"7","author":"Villalba","year":"2020","journal-title":"Eur J Case Rep. Intern Med."},{"issue":"7","key":"10.1016\/j.autrev.2021.102792_bb0515","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/alr.22592","article-title":"Self-reported olfactory loss associates with outpatient clinical course in COVID-19","volume":"10","author":"Yan","year":"2020","journal-title":"InInt. Forum Allergy Rhinol."},{"issue":"3","key":"10.1016\/j.autrev.2021.102792_bb0520","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4193\/Rhin20.116","article-title":"Presentation of new onset anosmia during the COVID-19 pandemic","volume":"58","author":"Hopkins","year":"2020","journal-title":"Rhinology."},{"issue":"20","key":"10.1016\/j.autrev.2021.102792_bb0525","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1001\/jama.2020.6771","article-title":"Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection","volume":"323","author":"Spinato","year":"2020","journal-title":"JAMA."},{"issue":"8","key":"10.1016\/j.autrev.2021.102792_bb0530","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/alr.22587","article-title":"Smell dysfunction: a biomarker for COVID-19","volume":"10","author":"Moein","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"9","key":"10.1016\/j.autrev.2021.102792_bb0535","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/alr.22593","article-title":"Potential pathogenesis of ageusia and anosmia in COVID-19 patients","volume":"10","author":"Vaira","year":"2020","journal-title":"Int. Forum Allergy Rhinol."},{"issue":"7798","key":"10.1016\/j.autrev.2021.102792_bb0540","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.autrev.2021.102792_bb0545","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1165\/ajrcmb.11.2.8049077","article-title":"Angiotensin-converting enzyme in the human nasal mucosa","volume":"11","author":"Ohkubo","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0550","first-page":"331","article-title":"Long term serious olfactory loss in colds and\/or flu","volume":"64","author":"Haro","year":"2013","journal-title":"Acta Otorrinolaringol. Esp."},{"issue":"15","key":"10.1016\/j.autrev.2021.102792_bb0555","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1128\/JVI.00737-08","article-title":"Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2","volume":"82","author":"Netland","year":"2008","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.autrev.2021.102792_bb0560","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11882-020-00961-1","article-title":"The loss of smell and taste in the COVID-19 outbreak: a tale of many countries","volume":"20","author":"Mullol","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"10.1016\/j.autrev.2021.102792_bb0565","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0570","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.medmal.2020.04.006","article-title":"Features of anosmia in COVID-19","volume":"50","author":"Klopfenstein","year":"2020","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.autrev.2021.102792_bb0575","series-title":"Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients","author":"Brann","year":"2020"},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0580","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12016-012-8343-x","article-title":"Smell and autoimmunity: a comprehensive review","volume":"45","author":"Perricone","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.autrev.2021.102792_bb0585","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fnins.2015.00318","article-title":"Impaired sense of smell and altered olfactory system in RAG-1(\u2212\u2215-) immunodeficient mice","volume":"9","author":"Rattazzi","year":"2015","journal-title":"Front. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.autrev.2021.102792_bb0590","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jneuroim.2014.04.003","article-title":"Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice","volume":"272","author":"Katzav","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.autrev.2021.102792_bb0595","series-title":"Corona (COVID-19) time musings: our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning Autoimmunity reviews","first-page":"102538","author":"Shoenfeld","year":"2020"},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0600","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.24491","article-title":"The sense of smell in systemic lupus erythematosus","volume":"60","author":"Shoenfeld","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.autrev.2021.102792_bb0605","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.12659\/MSM.915738","article-title":"Altered olfactory function in patients with systemic lupus erythematosus","volume":"25","author":"Chen","year":"2019","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.autrev.2021.102792_bb0610","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.autrev.2018.02.002","article-title":"Olfactory function in systemic lupus erythematosus and systemic sclerosis. A longitudinal study and review of the literature","volume":"17","author":"Bombini","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.autrev.2021.102792_bb0615","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ni1103-1043","article-title":"On the nose: shared themes for the sensory and immune self","volume":"4","author":"Doherty","year":"2003","journal-title":"Nat. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.autrev.2021.102792_bb0620","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neubiorev.2005.03.010","article-title":"The olfactory bulbectomised rat as a model of depression","volume":"29","author":"Song","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.autrev.2021.102792_bb0625","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0889-1591(02)00012-0","article-title":"The effect of thymectomy and IL-1 on memory: implications for the relationship between immunity and depression","volume":"16","author":"Song","year":"2002","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.autrev.2021.102792_bb0630","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1542\/hpeds.2020-0123","article-title":"COVID-19 and Kawasaki disease: novel virus and novel case","volume":"10","author":"Jones","year":"2020","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.autrev.2021.102792_bb0635","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and Antiphospholipid antibodies in patients with COVID-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.autrev.2021.102792_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2019.100766","article-title":"Three decades of messenger RNA vaccine development","volume":"28","author":"Verbeke","year":"2019","journal-title":"Nano Today"},{"issue":"1","key":"10.1016\/j.autrev.2021.102792_bb0645","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"ASIA\u2019\u2013autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J. Autoimmun."}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:22:22Z","timestamp":1761600142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1568997221000550"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102792","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102792"}}